Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

[Treatment of type 2 diabetes mellitus--which role do GLP-1 receptor agonists play?].

Lüdemann J.

MMW Fortschr Med. 2011 Jul 21;153 Suppl 2:56-63. Review. German.

PMID:
23964469
2.

[Glucagon-like peptide 1 (GLP-1)].

Parhofer KG.

MMW Fortschr Med. 2007 Jun 21;149(25-26):41-3. German.

PMID:
17713050
3.
4.

Current treatments and strategies for type 2 diabetes: can we do better with GLP-1 receptor agonists?

Peterson G.

Ann Med. 2012 Jun;44(4):338-49. doi: 10.3109/07853890.2011.653392. Review.

PMID:
22530845
5.

Emerging GLP-1 receptor agonists.

Lund A, Knop FK, Vilsbøll T.

Expert Opin Emerg Drugs. 2011 Dec;16(4):607-18. doi: 10.1517/14728214.2011.616493. Epub 2011 Sep 9. Review.

PMID:
21905764
6.

GLP-1 receptor agonists: a clinical perspective on cardiovascular effects.

Mundil D, Cameron-Vendrig A, Husain M.

Diab Vasc Dis Res. 2012 Apr;9(2):95-108. doi: 10.1177/1479164112441526. Review.

PMID:
22496442
7.

GLP-1 receptor agonists: targeting both hyperglycaemia and disease processes in diabetes.

Holst JJ, Seino Y.

Diabetes Res Clin Pract. 2009 Jul;85(1):1-3. doi: 10.1016/j.diabres.2009.02.017. Epub 2009 Mar 18. No abstract available.

PMID:
19299027
8.

[New concepts in the treatment of type 2 diabetes].

Meier JJ, Schmidt WE, Klein HH.

Internist (Berl). 2007 Jul;48(7):698, 700-7. Review. German.

PMID:
17541529
9.

The pharmacologic basis for clinical differences among GLP-1 receptor agonists and DPP-4 inhibitors.

Morales J.

Postgrad Med. 2011 Nov;123(6):189-201. doi: 10.3810/pgm.2011.11.2508. Erratum in: Postgrad Med. 2012 Jan;124(1):177-8.

PMID:
22104467
10.

Glucagon-like peptide-1 analog and insulin combination therapy in the management of adults with type 2 diabetes mellitus.

Tzefos M, Olin JL.

Ann Pharmacother. 2010 Jul-Aug;44(7-8):1294-300. doi: 10.1345/aph.1P047. Epub 2010 Jun 8. Review.

PMID:
20530705
11.

[Improved blood sugar control plus weight loss].

Göke B.

MMW Fortschr Med. 2006 Aug 17;148(33-34):51. German. No abstract available.

PMID:
16981389
12.

Liraglutide achieves A1C targets more often than sitagliptin or exenatide when added to metformin in patients with type 2 diabetes and a baseline A1C <8.0%.

King AB, Montanya E, Pratley RE, Blonde L, Svendsen CB, Donsmark M, Sesti G.

Endocr Pract. 2013 Jan-Feb;19(1):64-72. doi: 10.4158/EP12232.OR.

PMID:
23186975
13.

A multiplicity of targets: evaluating composite endpoint studies of the GLP-1 receptor agonists in type 2 diabetes.

Ross SA.

Curr Med Res Opin. 2015 Jan;31(1):125-35. doi: 10.1185/03007995.2014.973939. Epub 2014 Nov 4. Review.

PMID:
25299351
14.

The effect of liraglutide added to U-500 insulin in patients with type 2 diabetes and high insulin requirements.

Lane W, Weinrib S, Rappaport J.

Diabetes Technol Ther. 2011 May;13(5):592-5. doi: 10.1089/dia.2010.0221. Epub 2011 Mar 15.

PMID:
21406014
15.
16.

Glucagon-like peptide-1 receptor agonists as insulin add-on therapy in patients with inadequate glycemic control in type 2 diabetes mellitus: lixisenatide as a new therapeutic option.

Gómez-Huelgas R, Azriel S, Puig-Domingo M, Vidal J, de Pablos-Velasco P.

Int J Clin Pharmacol Ther. 2015 Mar;53(3):230-40. doi: 10.5414/CP202052. Review.

PMID:
25066229
17.

Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials.

Monami M, Marchionni N, Mannucci E.

Eur J Endocrinol. 2009 Jun;160(6):909-17. doi: 10.1530/EJE-09-0101. Epub 2009 Mar 24.

18.

GLP-1 receptor agonists for type 2 diabetes mellitus: recent developments and emerging agents.

Trujillo JM, Nuffer W.

Pharmacotherapy. 2014 Nov;34(11):1174-86. doi: 10.1002/phar.1507. Review.

PMID:
25382096
19.

Exenatide and liraglutide: different approaches to develop GLP-1 receptor agonists (incretin mimetics)--preclinical and clinical results.

Madsbad S.

Best Pract Res Clin Endocrinol Metab. 2009 Aug;23(4):463-77. doi: 10.1016/j.beem.2009.03.008. Review.

PMID:
19748064
20.

[Exenatide--an incretin-mimetic agent for the treatment of type 2 diabetes mellitus].

Reuter H, Erdmann E.

Dtsch Med Wochenschr. 2007 Mar 16;132(11):571-4. Review. German.

PMID:
17342635
Items per page

Supplemental Content

Write to the Help Desk